Drawing for MICROBIAL INSPIRED THERAPEUTICS

USPTO serial 88031390

MICROBIAL INSPIRED THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 7055509Status 700Registered
Filing date
Status date
Registration date
May 16, 2023
Examiner
DUONG, ANGELA GAW
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MICROBIAL INSPIRED THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ian W. Gillies

Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET14TH FLOORIRVINE, CA 92614

Goods and services

ClassDescriptionStatusFirst use
001Chemical or biochemical products, namely, small molecules, probiotic bacteria, probiotic bacterial cultures, and/or microbes for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, and/or any disease or disorder associated with leaky gut; microbes, chemicals and/or biochemicals for use in the manufacture of pharmaceutical preparations, probiotic supplements, and/or nutritional supplements; probiotic bacteria, probiotic bacterial cultures, and/or biochemicals for in vitro scientific or research useACTIVEOct 1, 2022
005Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, and/or any disease or disorder associated with leaky gutACTIVENov 24, 2022
042Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for othersACTIVEMar 15, 2023
044Providing medical information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trialsACTIVEMar 15, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 16, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 11, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 10, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 23, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 15, 2023IUAFUSE AMENDMENT FILED—
Mar 15, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 4, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 3, 2022EX5GSOU EXTENSION 5 GRANTED—
Sep 22, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 9, 2022EXT5SOU EXTENSION 5 FILED—
Sep 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 11, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 9, 2022EX4GSOU EXTENSION 4 GRANTED—
Mar 9, 2022EXT4SOU EXTENSION 4 FILED—
Mar 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 1, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 30, 2021EX3GSOU EXTENSION 3 GRANTED—
Aug 30, 2021EXT3SOU EXTENSION 3 FILED—
Aug 30, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 24, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 10, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 8, 2021EX2GSOU EXTENSION 2 GRANTED—
Feb 8, 2021EXT2SOU EXTENSION 2 FILED—
Feb 8, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 18, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 16, 2020EX1GSOU EXTENSION 1 GRANTED—
Sep 16, 2020EXT1SOU EXTENSION 1 FILED—
Sep 16, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 17, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 19, 2019ALIEASSIGNED TO LIE—
Dec 17, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 23, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 22, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 22, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 29, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 29, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 30, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 29, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 29, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 30, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2018DOCKASSIGNED TO EXAMINER—
Jul 14, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 13, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance